WH Reviewing FDA Draft Guide On Non-Opioid Pain Medicines

The White House is reviewing an FDA draft guidance that will address development of non-opioid drugs for acute pain, coming as lawmakers and public health experts push for more non-opioid, non-addictive pain medicines to help curb opioid addiction. FDA sent the draft guide, “Development of Non-Opioid Analgesics for Acute Pain,” to the White House Office of Management and Budget for review on Thursday (Dec. 2). The draft guide has not previously been published in the agency’s Unified Agenda, but in...